You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 266 No. 21, December 4, 1991 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Incidence and risk factors for gout in white men

R. Roubenoff, M. J. Klag, L. A. Mead, K. Y. Liang, A. J. Seidler and M. C. Hochberg
Division of Molecular and Clinical Rheumatology, Johns Hopkins University School of Hygiene and Public Health, Baltimore, Md.

OBJECTIVE--To identify potentially modifiable risk factors for the development of gout. DESIGN--Longitudinal cohort study (The Johns Hopkins Precursors Study). PARTICIPANTS--Of 1337 eligible medical students, 1271 (95%) received a standardized medical examination and questionnaire during medical school. The participants were predominantly male (91%), white (97%), and young (median age, 22 years) at cohort entry. OUTCOME MEASURE--The development of gout. RESULTS--Sixty cases of gout (47 primary and 13 secondary) were identified among 1216 men; none occurred among 121 women (P = .01). The cumulative incidence of all gout was 8.6% among men (95% confidence interval, 5.9% to 11.3%). Body mass index at age 35 years (P = .01), excessive weight gain (greater than 1.88 kg/m2) between cohort entry and age 35 years (P = .007), and development of hypertension (P = .004) were significant risk factors for all gout in univariate analysis. Multivariate Cox proportional hazards models confirmed the association of body mass index at age 35 years (relative risk [RR] = 1.12; P = .02), excessive weight gain (RR = 2.07; P = .02), and hypertension (RR = 3.26; P = .002) as risk factors for all gout. Hypertension, however, was not a significant risk factor for primary gout. CONCLUSIONS--Obesity, excessive weight gain in young adulthood, and hypertension are risk factors for the development of gout. Prevention of obesity and hypertension may decrease the incidence of and morbidity from gout; studies of weight reduction in the primary and secondary prevention of gout are indicated.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Effect of Age and Gender on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase
Khosravan et al.
J Clin Pharmacol 2008;48:1014-1024.
ABSTRACT | FULL TEXT  

Serum Urate as a Predictor of Clinical and Radiographic Progression in Parkinson Disease
Schwarzschild et al.
Arch Neurol 2008;65:716-723.
ABSTRACT | FULL TEXT  

Effects of diet, physical activity and performance, and body weight on incident gout in ostensibly healthy, vigorously active men
Williams
Am. J. Clin. Nutr. 2008;87:1480-1487.
ABSTRACT | FULL TEXT  

Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels--the Third National Health and Nutrition Examination Survey
Choi and Ford
Rheumatology (Oxford) 2008;47:713-717.
ABSTRACT | FULL TEXT  

Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study
Choi and Curhan
BMJ 2008;336:309-312.
ABSTRACT | FULL TEXT  

Independent Impact of Gout on Mortality and Risk for Coronary Heart Disease
Choi and Curhan
Circulation 2007;116:894-900.
ABSTRACT | FULL TEXT  

Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs.
Khosravan et al.
J Clin Pharmacol 2006;46:855-866.
ABSTRACT | FULL TEXT  

The Effect of Mild and Moderate Hepatic Impairment on Pharmacokinetics, Pharmacodynamics, and Safety of Febuxostat, a Novel Nonpurine Selective Inhibitor of Xanthine Oxidase
Khosravan et al.
J Clin Pharmacol 2006;46:88-102.
ABSTRACT | FULL TEXT  

Pathogenesis of Gout
Choi et al.
ANN INTERN MED 2005;143:499-516.
FULL TEXT  

Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD)
Mikuls et al.
Rheumatology (Oxford) 2005;44:1038-1042.
ABSTRACT | FULL TEXT  

Obesity, Weight Change, Hypertension, Diuretic Use, and Risk of Gout in Men: The Health Professionals Follow-up Study
Choi et al.
Arch Intern Med 2005;165:742-748.
ABSTRACT | FULL TEXT  

Gout epidemiology: results from the UK General Practice Research Database, 1990-1999
Mikuls et al.
Ann Rheum Dis 2005;64:267-272.
ABSTRACT | FULL TEXT  

Purine-Rich Foods and the Risk of Gout in Men
Dohan et al.
NEJM 2004;350:2520-2521.
FULL TEXT  

Purine-Rich Foods, Dairy and Protein Intake, and the Risk of Gout in Men
Choi et al.
NEJM 2004;350:1093-1103.
ABSTRACT | FULL TEXT  

A case-control study of the association of diet and obesity with gout in Taiwan
Lyu et al.
Am. J. Clin. Nutr. 2003;78:690-701.
ABSTRACT | FULL TEXT  

Joint Injury in Young Adults and Risk for Subsequent Knee and Hip Osteoarthritis
Gelber et al.
ANN INTERN MED 2000;133:321-328.
ABSTRACT | FULL TEXT  

Hyperlipidaemia in hyperuricaemia and gout
EMMERSON
Ann Rheum Dis 1998;57:509-510.
FULL TEXT  

The Management of Gout
Emmerson
NEJM 1996;334:445-451.
FULL TEXT  

RISK FACTORS FOR GOUT
JWatch General 1991;1991:4-4.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.